STTK·82024L103·US·equity·Healthcare - Biotechnology-Activist
STTK (SHATTUCK LABS INC) is held by 52 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($29.9M), Aberdeen Group plc ($7.5M), Point72 Asset Management, L.P. ($6.6M). Net institutional sentiment: Bullish.
See how STTK's score breaks down across 4 SEC sources
Showing 1-20 of 54
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer